Understanding Side Effects When Switching Between GLP-1 Treatments
Mounjaro vs Wegovy Side Effects: Key Differences for Switchers
When comparing Mounjaro vs Wegovy side effects, the primary difference lies in their mechanisms of action. Mounjaro (tirzepatide) targets both GIP and GLP-1 receptors, whilst Wegovy (semaglutide) works solely on GLP-1 receptors. This dual-action approach of Mounjaro may increase the likelihood of gastrointestinal side effects for some patients, including nausea, vomiting, and diarrhoea. Patients switching to Wegovy often report a more manageable side effect profile, particularly regarding digestive tolerance during the initial weeks of treatment.
The most common side effects when transitioning from Mounjaro to Wegovy include temporary nausea, which typically diminishes as your body adjusts to the single-receptor approach. Clinical data suggests that the gradual dose escalation protocol with Wegovy—starting at 0.25mg and increasing every four weeks—helps minimise side effects compared to switching directly between maintenance doses. Both medications require careful monitoring, but Wegovy's established STEP trial safety profile provides reassurance for patients concerned about Mounjaro vs Wegovy side effects during their weight management journey.
Switch & Save: Wegovy Pricing and Value Comparison
Switching from Mounjaro to Wegovy can offer significant cost advantages through our competitive pricing structure. Single pen prices start at £79.99 for the 0.25mg starter dose, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide excellent value, with the Intro Duo (0.25mg & 0.5mg) available for £169.99, and the Progress Duo (0.5mg & 1mg) priced at £189.99. New customers can apply code FIRST40 at checkout, whilst returning customers benefit from code DOSE25 to reach these competitive prices.
For patients requiring consistent dosing during their transition, our Stay Steady bundles offer convenience and value. The Consistency 0.25mg bundle (two pens) costs £139.99, perfect for patients who need extended time at the starting dose when switching treatments. Three-pen bundles provide even greater convenience, with the Intro Trio (0.25mg, 0.5mg & 1mg) available for £299.99, ensuring a smooth transition period. Our Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99, ideal for patients who have successfully switched and want to secure their ongoing treatment.
Clinical Evidence: Wegovy Side Effect Profile vs Mounjaro
The STEP clinical trial programme, as reported by Wilding et al. in the New England Journal of Medicine (2021), provides comprehensive safety data for Wegovy in weight management. In STEP 1, the most common side effects were gastrointestinal, affecting approximately 44% of patients with nausea, 25% with diarrhoea, and 24% with vomiting during the dose escalation phase. Importantly, these effects were generally mild to moderate and decreased over time as patients adjusted to treatment.
When comparing Mounjaro vs Wegovy side effects based on their respective clinical trials, both medications show similar gastrointestinal tolerability profiles, though individual responses may vary significantly. The STEP trials demonstrated that serious adverse events were rare, occurring in less than 5% of participants, and treatment discontinuation due to side effects occurred in approximately 7% of patients. These findings suggest that patients experiencing intolerable side effects with Mounjaro may find Wegovy's single-receptor mechanism more suitable for their individual physiology.
How Wegovy Works: Understanding the Side Effect Mechanism
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of a natural hormone that regulates blood sugar and appetite. Unlike Mounjaro's dual-receptor approach, Wegovy's selective action on GLP-1 receptors may result in fewer complex interactions and a more predictable side effect profile. The medication works by slowing gastric emptying, which can initially cause nausea and feelings of fullness, but these effects typically diminish as the digestive system adapts. Wegovy also acts on appetite centres in the brain, reducing food cravings and promoting satiety after smaller meals. The once-weekly injection schedule using the FlexTouch pen system ensures consistent medication levels, helping to minimise fluctuations that might contribute to side effects. This steady-state approach often makes the transition from daily or weekly Mounjaro injections more comfortable for patients concerned about Mounjaro vs Wegovy side effects during their switching period.
Seamless Switching: EverydayMeds Order Process
Transitioning from Mounjaro to Wegovy through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, which considers your previous treatment experience and any side effects encountered. Our qualified prescribers, working within our GPhC-registered pharmacy (#9012878), review your medical history and current medications to determine the most appropriate Wegovy starting dose for your transition. Standard prescriber review takes 3 working days, with express 24-hour review available for urgent switches. Once approved, your Wegovy prescription is dispatched via next-day delivery using our specialised cold-chain, temperature-controlled packaging to ensure medication integrity. This streamlined process eliminates the need to register with multiple pharmacies, making your switch from Mounjaro to Wegovy as smooth as possible whilst maintaining continuity of care.
Storage Advantages: Wegovy vs Mounjaro Practical Considerations
One significant advantage when switching from Mounjaro to Wegovy involves storage flexibility, which can impact treatment adherence and travel convenience. Wegovy pens maintain stability for up to 6 weeks at room temperature below 30°C once removed from refrigerated storage, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy particularly suitable for patients who travel frequently or experience difficulty maintaining consistent refrigeration. The FlexTouch pen system used for Wegovy delivers precise doses through a simple injection process, with clear dose escalation markings to prevent administration errors during the switching period. Proper storage at 2-8°C before first use ensures optimal medication potency, whilst the extended room temperature tolerance provides peace of mind for patients concerned about accidental temperature exposure. These practical advantages can significantly reduce anxiety about medication management when comparing Mounjaro vs Wegovy side effects and overall treatment experience.
Personalised Switching Strategy: Minimising Transition Side Effects
Successfully managing Mounjaro vs Wegovy side effects during the switching process requires a personalised approach based on your previous treatment response. Patients who experienced significant nausea with Mounjaro may benefit from an extended period at Wegovy's 0.25mg starting dose, allowing the digestive system to adjust gradually to the new medication mechanism. Our clinical team can recommend dietary modifications during the transition, such as smaller, more frequent meals and avoiding high-fat foods that might exacerbate gastrointestinal side effects. Some patients find that switching during a period of stable routine, away from travel or work stress, helps minimise the impact of any temporary side effects.
The timing of your switch from Mounjaro to Wegovy can also influence side effect management, with many patients preferring to begin Wegovy treatment on the same day of the week they previously used for Mounjaro injections. This consistency helps maintain routine whilst allowing for direct comparison of any side effects between the two treatments. Regular monitoring through our clinical support system ensures that any concerning symptoms are addressed promptly, with dose adjustment recommendations made as needed. This comprehensive switching support distinguishes EverydayMeds from other providers and ensures optimal outcomes when transitioning between weight management treatments.
Complete Your Switch Today: Expert Support and Competitive Pricing
Ready to explore whether Wegovy offers a better side effect profile than Mounjaro for your weight management goals? EverydayMeds provides the complete solution with both medications available from one trusted GPhC-registered pharmacy (#9012878), competitive pricing, and expert clinical support throughout your transition. Start your Wegovy journey with confidence using our proven 3-minute assessment process, backed by our qualified prescribers who understand the complexities of switching between GLP-1 treatments. New customers can apply discount code FIRST40 at checkout, whilst returning customers benefit from code DOSE25, ensuring you receive the best possible value for your prescription-only medicine. Don't let concerns about Mounjaro vs Wegovy side effects prevent you from optimising your weight management treatment—take the first step towards a more suitable medication today. Visit our weight loss collection at https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and experience the EverydayMeds difference in personalised care and competitive pricing.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
